Date of download: 7/7/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in First Complete Remission: Systematic Review and Meta-analysis of Prospective Clinical Trials JAMA. 2009;301(22): doi: /jama ITT indicates intention-to-treat; SCT, stem cell transplantation. a The most updated report was included. Figure Legend:

Date of download: 7/7/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in First Complete Remission: Systematic Review and Meta-analysis of Prospective Clinical Trials JAMA. 2009;301(22): doi: /jama Black rectangles indicate summary effects estimates (hazard ratios [HRs]) for individual study reports. Sizes of data markers are proportional to the study weights. Error bars indicate 95% confidence intervals (CIs). AML indicates acute myeloid leukemia; RFS, relapse-free survival. a Studies only reporting RFS end points. Figure Legend:

Date of download: 7/7/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in First Complete Remission: Systematic Review and Meta-analysis of Prospective Clinical Trials JAMA. 2009;301(22): doi: /jama Black rectangles indicate summary effects estimates (hazard ratios [HRs]) for individual study reports. Sizes of data markers are proportional to the study weights. Error bars indicate 95% confidence intervals (CIs). AML indicates acute myeloid leukemia. Figure Legend: